Ajanta Pharma Ltd. (AJANTPHARM) Share Price Hits Fresh 52-Week High
- August 18, 2026
- Posted by: Harsh Piplani
- Category: News
Ajanta Pharma Ltd. Share Price traded at Rs 3,725, up 0.32% today, after hitting a fresh 52-week high of Rs 3,796.95. Market capitalisation stood at Rs 45,924.32 crore.
Ajanta Pharma Ltd. Share Price was at Rs 3,725 on 18 August 2026, up Rs 11.9 or 0.32% from the previous close of Rs 3,713.1, after the stock touched a fresh 52-week high of Rs 3,796.95 in intraday trade. The company’s market capitalisation stood at Rs 45,924.32 crore, putting the move firmly on the radar of investors tracking Healthcare names and 52 Week High Stocks in the Indian Stock Market.
For investors searching Ajanta Pharma Ltd. Share Price Today, the verified data confirms a new one-year high, a day open of Rs 3,713.5, a low of Rs 3,709.1, turnover of Rs 1.25 crore and current volume of 3,344 shares. The supplied data confirms the price event, but it does not establish a company-specific catalyst behind today’s move. That matters because Ajanta Pharma Ltd. Stock News is currently being driven by the market event itself rather than any verified corporate trigger in the supplied dataset.
From a Univest stock analysis perspective, the move is notable for two reasons. First, the stock has extended to a yearly high while holding above the previous close. Second, the valuation and profitability data create a more mixed Fundamental Analysis backdrop: the P/E ratio is 170.32, P/B ratio is 0.42, ROE is -2.89 and ROCE is -0.26. That makes Ajanta Pharma Ltd. Share Price News relevant not only for momentum watchers, but also for investors comparing valuation and profitability against Healthcare sector benchmarks and listed peers.
Ajanta Pharma Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,725 |
| Previous Close | Rs 3,713.1 |
| Today's Change | +Rs 11.9 (+0.32%) |
| Day Open | Rs 3,713.5 |
| Fresh 52-Week High | Rs 3,796.95 |
| Day Low | Rs 3,709.1 |
| Current Volume | 3,344 |
| Turnover | Rs 1.25 crore |
| Market Capitalisation | Rs 45,924.32 crore |
Ajanta Pharma Ltd. (AJANTPHARM) traded at Rs 3,725. versus the previous close of Rs 3,713.1, a rise of 0.32%. The stock opened at Rs 3,713.5, reached Rs 3,796.95, touched Rs 3,709.1. Reported volume was 3,344.
Ajanta Pharma Ltd. Share Price Today shows a fresh 52-week high event with a modest day gain. The stock traded at Rs 3,725 versus the previous close of Rs 3,713.1, rose Rs 11.9 or 0.32%, opened at Rs 3,713.5, touched Rs 3,796.95 and slipped to a low of Rs 3,709.1.
What exactly happened today is clear from the verified price action. Ajanta Pharma Ltd. Share Price opened almost flat to the previous close, then stretched to Rs 3,796.95, which marked a fresh 52-week peak. Even though the stock later traded below the session high at Rs 3,725, it remained in positive territory on the day, keeping the one-year high event intact.
The intraday range between Rs 3,709.1 and Rs 3,796.95 shows that traders were willing to push the stock into new high ground, even if some profit-booking or intraday supply emerged after the peak. Turnover stood at Rs 1.25 crore and current volume was 3,344 shares, which gives a factual snapshot of participation in today’s price action. For readers following Ajanta Pharma Ltd. Share Price Live and Ajanta Pharma Ltd. Share News, that combination of a new yearly high and a positive close-versus-previous-close setup explains why the stock is featuring in Stock Market Today searches and market movers screens.
At Univest, this kind of price action is usually where short-term momentum interest begins, but the next step is to place the move against the company’s valuation and profitability profile rather than reading the 52-week high in isolation.
Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 45,924.32 crore |
| P/E Ratio | 170.32x |
| P/B Ratio | 0.42x |
| ROE | -2.89% |
| ROCE | -0.26% |
Ajanta Pharma Ltd. was valued at a P/E ratio of 170.32x, a P/B ratio of 0.42x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 170.32x |
| Benchmark Median P/E | 21x |
| Benchmark Average P/E | 49.19x |
| Benchmark P/E Range | 0x to 1,598.54x |
| Company P/B Ratio | 0.42x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 45,924.32 crore |
| Benchmark Median Market Cap | Rs 136.28 crore |
Ajanta Pharma Ltd. (AJANTPHARM) is classified under sector: Healthcare.
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 170.32x, which is above the benchmark median of 21x, a difference of +711.05%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ajanta Pharma Ltd. (AJANTPHARM) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Ajanta Pharma Ltd. (AJANTPHARM) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,985.15 | 170.32 | 0.42 | -2.89 | -0.26 |
| Beta Drugs Ltd. | BETA | 2,827.67 | 65.02 | 10.29 | 18.65 | 22.17 |
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,645.37 | 47.53 | 1.82 | -0.78 | 8.31 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,562.17 | 33.62 | 6.93 | -2.6 | 16.92 |
| Fredun Pharmaceuticals Ltd. | FREDUN | 2,559.68 | 54.85 | 8.19 | 11.42 | 13.15 |
Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 170.32x compared with the displayed peer median of 54.85x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of Rs 45,924.32 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Ajanta Pharma Ltd.
The stock is getting attention because the verified dataset shows a fresh 52-week high alongside a large market capitalisation and an unusual mix of valuation and return metrics. That combination tends to place a stock in Stocks in News and Share Market Today discussions.
- Fresh 52-week high: Ajanta Pharma Ltd. Share Price touched Rs 3,796.95, its new one-year high.
- Positive day move: The stock traded at Rs 3,725, up Rs 11.9 or 0.32% from Rs 3,713.1.
- Intraday activity: The day range ran from Rs 3,709.1 to Rs 3,796.95, with turnover of Rs 1.25 crore and volume of 3,344 shares.
- Large market value: The company’s market capitalisation is Rs 45,924.32 crore, far above the supplied Healthcare benchmark averages.
- Mixed fundamentals: P/E is 170.32 and P/B is 0.42, while ROE is -2.89 and ROCE is -0.26.
- Sector positioning: The stock’s earnings multiple is above the same-sector median and average, making relative valuation a key area to monitor.
About Ajanta Pharma Ltd.
Ajanta Pharma Ltd. (AJANTPHARM) is tracked in the supplied dataset within the Healthcare sector. In the peer and benchmark universe attached to this event, most comparable names are classified under Pharmaceuticals & Drugs, while one listed peer falls under Hospital & Healthcare Services. That places Ajanta Pharma Ltd. Share Price within a broader healthcare-focused market context used for valuation and profitability comparison.
Based on the supplied event data, the company is being assessed here primarily through market metrics rather than business-segment disclosures. Investors following Ajanta Pharma Ltd. Company News and Ajanta Pharma Ltd. Latest News are currently seeing the stock through three lenses: a fresh 52 Week High, a market capitalisation of Rs 45,924.32 crore and a ratio profile that differs sharply from sector medians on P/E, P/B, ROE and ROCE. On Univest, that makes the stock relevant both for daily market update tracking and for deeper sector-relative comparison.
Track Ajanta Pharma Ltd. Share Price on Univest
Use Ajanta Pharma Ltd. (AJANTPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors tracking Ajanta Pharma Ltd. Share Price can use Univest to follow live share price movements, 52-week high and 52-week low levels, market capitalisation, valuation ratios, peer comparison and broader market insights. Univest also helps users monitor Ajanta Pharma Ltd. Share Price Today alongside stock performance screens, sector context and ownership disclosures whenever available in the verified dataset.
For readers looking up Ajanta Pharma Ltd. Stock News, Ajanta Pharma Ltd. Share Price Update or Ajanta Pharma Ltd. Latest News, Univest organizes price action, fundamental ratios and comparative market data in one place. That is especially useful when a stock enters a fresh yearly high zone and investors want to track whether the focus remains on price action, valuation, peer positioning or wider Healthcare sector trends.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest Ajanta Pharma Ltd. Share Price today?
Ans. Ajanta Pharma Ltd. Share Price today was Rs 3,725 at the time of the article. The stock was up Rs 11.9 or 0.32% from the previous close of Rs 3,713.1 after touching a fresh 52-week high.
What was the fresh 52-week high of Ajanta Pharma Ltd. Share Price?
Ans. Ajanta Pharma Ltd. Share Price hit a fresh 52-week high of Rs 3,796.95 in intraday trade. The stock later traded at Rs 3,725, which still kept it above the previous close and preserved the one-year high event.
Why is Ajanta Pharma Ltd. Share Price rising today?
Ans. The supplied data confirms that Ajanta Pharma Ltd. Share Price rose 0.32% and reached a fresh 52-week high today. However, the verified dataset for this article does not establish any company-specific catalyst behind the move.
What does today’s price action show for Ajanta Pharma Ltd. Share Price?
Ans. Today’s price action shows Ajanta Pharma Ltd. Share Price opened at Rs 3,713.5, touched Rs 3,796.95, slipped to Rs 3,709.1 and traded at Rs 3,725. That reflects a broad intraday range with a new yearly high.
What is the market capitalisation of Ajanta Pharma Ltd.?
Ans. Ajanta Pharma Ltd. had a market capitalisation of Rs 45,924.32 crore in the supplied data. That is much higher than the Healthcare benchmark median of Rs 136.28 crore and average of Rs 468.36 crore.
Is Ajanta Pharma Ltd. Share Price expensive on P/E basis?
Ans. Ajanta Pharma Ltd. Share Price has a P/E ratio of 170.32. That is above the Healthcare sector median of 21 and average of 49.19 in the supplied 196-company benchmark, indicating a richer earnings multiple.
How does Ajanta Pharma Ltd. compare on P/B ratio?
Ans. Ajanta Pharma Ltd. has a P/B ratio of 0.42. This is below the Healthcare sector median of 1.9 and average of 2.6, so the stock appears lower on book-value valuation than the benchmark centre.
What do the ROE and ROCE figures show for Ajanta Pharma Ltd.?
Ans. The supplied data shows ROE of -2.89 and ROCE of -0.26 for Ajanta Pharma Ltd. Both are below the Healthcare benchmark medians of 10.92 and 13.29, pointing to weaker reported return ratios in this snapshot.
How does Ajanta Pharma Ltd. compare with peers?
Ans. Ajanta Pharma Ltd. has the largest market capitalisation among the supplied peers at Rs 45,924.32 crore. Its P/E of 170.32 is above most peers, while its ROE and ROCE are weaker than several peer companies.
What should investors monitor next in Ajanta Pharma Ltd. Share Price?
Ans. Investors can monitor whether Ajanta Pharma Ltd. Share Price holds near its fresh 52-week high, while also tracking valuation against sector benchmarks, peer profitability metrics, turnover of Rs 1.25 crore and volume of 3,344 shares.
